Contact US

NeoMed Announces Release of NeoConnect Certification Program

NeoMed, Inc. announces the launch of the “NeoConnect® Certification Program for ENFit®.”  The curriculum was devel­oped as an essen­tial resource to assist NeoMed customers during the global tran­si­tion to ENFit.  The NeoConnect Certification Program is designed for clin­i­cians to demon­strate and docu­ment clin­ical compe­tency with managing the use of ENFit prod­ucts to enhance patient outcome by addressing essen­tial topics such as:

  • Compliance with GEDSA Guidelines to admin­ister low volume doses using the Low Dose Tip Syringe
  • Impact of the moat during small volume doses to preserve dose accu­racy
  • Identifying protocol changes
  • Maintaining current processes
  • Characterizing successful facility tran­si­tions
  • Enhancing produc­tivity
  • Maximizing Ease of Use
  • Feeding tube hub cleaning proce­dures that support ASPEN recom­men­da­tions

NeoConnect® Certification is achieved after clin­i­cians undergo ENFit product, proce­dure, and simu­la­tion training.  Post-training testing helps ensure that partic­i­pants possess the knowl­edge base to train other clin­i­cians and health care profes­sionals as the industry tran­si­tions to ENFit.  NeoMed has imple­mented over 60 successful ENFit conver­sions, repre­senting an esti­mated 2,600,000 deliv­ered enteral and medica­tion admin­is­tra­tions.

In prepa­ra­tion for this ongoing clin­ical project, NeoMed completed NeoConnect Certification Training for its domestic Sales Organization during the NeoMed National Sales Meeting recently held in Atlanta, Georgia.  This will allow the entire sales team to assist clin­i­cians with this impor­tant imple­men­ta­tion initia­tive.

Aaron Ingram, NeoMed President, states “NeoMed’s Certification Program is funda­mental to driving a successful tran­si­tion by helping ensure clin­ical under­standing of work flow processes and the neces­sity of ENFit compe­tency during the tran­si­tion to ENFit.  It provides customers with the docu­mented exper­tise and the skill set required to support conver­sions to ENFit.”

Over 7,000 U.S. hospi­tals are preparing for the tran­si­tion to ENFit.  NeoMed has devel­oped a number of addi­tional programs, such as the “NeoMed Transition Program,” that help navi­gate this global conver­sion.  Collectively, these programs help to iden­tify hospital staff training needs, estab­lish, and review process proto­cols, and ensure supply chain integrity before conver­sion.

NeoMed develops inno­v­a­tive enteral collec­tion and delivery prod­ucts supporting the special­ized feeding and medica­tion dosing needs of the low birth weight, neonatal, and pedi­atric patients.  We are committed to improve patient outcomes through product designs that meet safety, clin­ical, and regu­la­tory guide­lines while supporting cost contain­ment objec­tives.

NM-1001 Rev 0